US$ 25.24
aod9604 inhibits lipogenesis What Do Clinical Trials Indicate About the Fat-Burning Potential of AO – Prime Lab Peptides AOD-9604 5 mg | Fat
Description
This gives you four zones per thigh and eight zones total across both legs

doi: 10.1016/j.tem.2006.05.005

Safety, Regulation, and Quality Concerns From a regulatory perspective, AOD 9604 is not approved by the US FDA, and thus it has no approved medical indications

This muscle-sparing effect is valuable for body recomposition goals and maintaining metabolic rate during fat loss phases

It also plays a significant role in the metabolism of carbohydrates, fats, and proteins

Patient Characteristics Most patients in cohort 1 were female (62.2%), and the mean age was 70.4 years (standard deviation [SD],13.2)
